Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy

Journal of Neural Transmission

Volumn 117, Issue 6, 2010, Pages 765-772

  Rudzińska, Monika ^a   Wójcik, Magdalena ^a   Szczudlik, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Botulinum toxin; Hemifacial spasm; Motor related symptoms; Non motor symptoms

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; DEPRESSION; DIPLOPIA; DISEASE DURATION; DRY EYE; EYE IRRITATION; FACIAL MUSCLE WEAKNESS; FEMALE; HEARING; HEMIFACIAL SPASM; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; MUSCLE CONTRACTION; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; PARESTHESIA; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; AUTONOMIC NERVOUS SYSTEM DISEASES; BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS; CHI-SQUARE DISTRIBUTION; FEMALE; HEMIFACIAL SPASM; HUMANS; MALE; MIDDLE AGED; MOVEMENT DISORDERS; NEUROMUSCULAR AGENTS; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77954538297     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-010-0416-5     Document Type: Article

References (36)

1. R Astarloa B Morales N Penafiel J Rbano JG de Yebenes 1991 Craniocervical dystonia and facial hemispasm: clinical and pharmacological characteristics of 52 patients Rev Clin Esp 189 320 324 1:STN:280:DyaK387hsF2htw%3D%3D 1767088
2. RG Auger JP Whisnant 1990 Hemifacial spasm in Rochester and Olmsted County, Minnesota, 1960 to 1984 Arch Neurol 47 11 1233 1234 1:STN:280: DyaK3M%2FltlyhtQ%3D%3D 2241620
3. A Berardelli JC Rothwell BL Day CD Marsden 1985 Pathophysiology of blepharospasm and oromandibular dystonia Brain 108 Pt 3 593 608 10.1093/brain/108.3.593 4041776
4. S Bielamowicz CL Ludlow 2000 Effects of botulinum toxin on pathophysiology in spasmodic dysphonia Ann Otol Rhinol Laryngol 109 2 194 203 1:STN:280:DC%2BD3c7kvVSjsg%3D%3D 10685573
5. A Currà C Trompetto G Abbruzzese A Berardelli 2004 Central effects of botulinum toxin type A: evidence and supposition Mov Disord 19 Suppl 8 S60 S64 10.1002/mds.20011 15027056 (Pubitemid 38967513)
6. G Defazio D Martino MS Aniello G Masi G Logroscino G Manobianca M La Stilla P Livrea 2003 Influence of age on the association between primary hemifacial spasm and arterial hypertension J Neurol Neurosurg Psychiatry 74 7 979 981 10.1136/jnnp.74.7.979 1:STN:280:DC%2BD3s3otlOgsw%3D%3D 12810800 (Pubitemid 36783013)
7. R Eleopra V Tugnoli L Caniatti D De Grandis 1996 Botulinum toxin treatment in the facial muscles of humans: evidence of an action in untreated near muscles by peripheral local diffusion Neurology 46 4 1158 1160 1:STN:280:DyaK28zntlyhsw%3D%3D 8780112
8. K Frei DD Truong D Dressler 2006 Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations Eur J Neurol 13 Suppl 1 30 35 10.1111/j.1468-1331.2006.01442.x 16417595
9. BR Frueh RA Preston DC Musch 1990 Facial nerve injury and hemifacial spasm Am J Ophthalmol 110 4 421 423 1:STN:280:DyaK3M%2Fit12gtQ%3D%3D 2220979
10. WJ Gardner 1968 Trigeminal neuralgia Clin Neurosurg 15 1 15 1:STN:280:DyaE38%2FpvVKitQ%3D%3D 4945158
11. CG Garner A Straube TN Witt T Gasser WH Oertel 1993 Time course of distant effects of local injections of botulinum toxin Mov Disord 8 1 33 37 10.1002/mds.870080106 1:STN:280:DyaK3s7isFGqug%3D%3D 8380486 (Pubitemid 23039227)
12. YC Huang JY Fan LS Ro, et al. 2009 Validation of a Chinese version of disease specific quality of life scale (HFS-36) for hemifacial spasm in Tajwan Health Qual Life Outcomes 7 104 10.1186/1477-7525-7-104 20034399
13. J Jankovic 2004 Botulinum toxin in clinical practice J Neurol Neurosurg Psychiatry 75 7 951 957 10.1136/jnnp.2003.034702 1:STN:280: DC%2BD2czgtVSltQ%3D%3D 15201348 (Pubitemid 38869604)
14. S Jitpimolmard S Tiamkao M Laopaiboon 1998 Long term results of botulinum toxin type A in the treatment of hemifacial spasm: a report of 175 cases J Neurol Neurosurg Psychiatry 64 751 757 10.1136/jnnp.64.6.751 1:STN:280:DyaK1czgvFGiuw%3D%3D 9647304
15. P Kanovský H Streitová J Dufek V Znojil P Daniel I Rektor 1998 Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A Mov Disord 13 1 108 117 10.1002/mds.870130122 9452335 (Pubitemid 28029861)
16. A Kuroki AR Moller 1994 Facial nerve demyelination and vascular compression are both needed to induce facial hyperactivity: a study in rats Acta Neurochir 126 149 157 10.1007/BF01476426 1:STN:280:DyaK2czhslGktg%3D%3D
17. DJ Lange M Rubin PE Greene UJ Kang CB Moskowitz MF Brin RE Lovelace S Fahn 1991 Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes Muscle Nerve 14 7 672 675 10.1002/mus. 880140711 1:STN:280:DyaK38%2Fhsl2ruw%3D%3D 1922173
18. P Martinelli S Giuliani M Ippoliti 1992 Hemifacial spasm due to peripheral injury of facial nerve: a nuclear syndrome Mov Disord 7 181 184 10.1002/mds.870070214 1:STN:280:DyaK383mtFKnuw%3D%3D 1584239
19. RS Maurice-Williams 1973 Tic convulsif: the association of trigeminal neuralgia and hemifacial spasm Postgrad Med J 49 576 742 745 10.1136/pgmj.49.576.742 1:STN:280:DyaE2c7jsFGqsA%3D%3D 4786441
20. AR Moller 1991 Interaction between the blink reflex and the abnormal muscle response in patients with hemifacial spasm: results of intraoperative recordings J Neurol Sci 101 114 123 10.1016/0022-510X(91)90025-3 1:STN:280:DyaK3M3isFOitw%3D%3D 2027024
21. AR Moller PJ Jannetta 1984 On the origin of synkinesis in hemifacial spasm: result of intracranial recording J Neurosurg 61 569 576 10.3171/jns.1984.61.3.0569 1:STN:280:DyaL2c3mslSitw%3D%3D 6086858
22. MB Moller AR Moller 1985 Loss of auditory function in microvascular decompression for hemifacial spasm J Neurosurg 63 17 20 10.3171/jns.1985.63.1. 0017 1:STN:280:DyaL2M3js1GhsA%3D%3D 4009269
23. M Naumann W Jost 2004 Botulinum toxin treatment of secretory disorders Mov Disord 19 Suppl 8 S137 S141 10.1002/mds.20067 15027066 (Pubitemid 38967523)
24. VK Nielsen 1984 Pathophysiology of hemifacial spasm: I. Ephaptic transmission and ectopic excitation Neurology 34 418 426 1:STN:280: DyaL2c7kt1KksQ%3D%3D 6322048
25. LD Oliveira F Cardoso AP Vargas 1999 Hemifacial spasm and arterial hypertension Mov Disord 14 5 832 835 10.1002/1531-8257(199909)14:5<832::AID- MDS1017>3.0.CO;2-7 1:STN:280:DyaK1MvitlagtQ%3D%3D 10495046 (Pubitemid 29509627)
26. J Reimer K Gilg A Karow, et al. 2005 Health-related quality of life in blepharospasm or hemifacial spasm Acta Neurol Scand 11 64 70 10.1111/j.1600-0404.2004.00357.x
27. P Schnider P Birner E Moraru E Au 1999 Long-term treatment with botulinum toxin: dosage treatment schedules and costs Wien Klin Wochenschr 111 59 65 1:STN:280:DyaK1M7otV2ltg%3D%3D 10081123
28. EK Tan LL Chan KK Koh 2004 Coexistent blepharospasm and hemifacial spasm: overlapping pathophysiologic mechanism? J Neurol Neurosurg Psychiatry 75 3 494 496 10.1136/jnnp.2003.019331 14966174 (Pubitemid 38338788)
29. EK Tan S Fook-Chong SY Lum, et al. 2004 Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30) J Neurol Scien 219 151 155 10.1016/j.jns.2004.01.010 1:CAS:528:DC%2BD2cXisF2gur0%3D (Pubitemid 38406011)
30. EK Tan SY Lum S Fook-Chong LL Chan C Gabriel L Lim 2005 Behind the facial twitch: depressive symptoms in hemifacial spasm Parkinsonism Relat Disord 11 4 241 245 10.1016/j.parkreldis.2004.12.003 15878585 (Pubitemid 40692836)
31. EK Tan S Hameed S Fook-Chong, et al. 2008 Treatment outcomes correlates with knowledge of disease in hemifacial spasm Clin Neurol Neurosurg 110 813 817 10.1016/j.clineuro.2008.05.010 18583029
32. J Valls-Sole ES Tolosa G Ribera 1991 Neurophysiological observations on the effects of botulinum toxin treatment in patients with dystonic blepharospasm J Neurol Neurosurg Psychiatry 54 4 310 313 10.1136/jnnp.54.4.310 1:STN:280:DyaK3M3nslOitg%3D%3D 1647444
33. A Wang J Jankowic 1998 Hemifacial spasm: clinical findings and treatment Muscle Nerve 21 1740 1747 10.1002/(SICI)1097-4598(199812)21:12<1740::AID- MUS17>3.0.CO;2-V 1:STN:280:DyaK1M%2Flslaisw%3D%3D 9843077 (Pubitemid 28545706)
34. H Wiegand G Erdmann HH Wellhöner 1976 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection Naunyn Schmiedebergs Arch Pharmacol 292 2 161 165 10.1007/BF00498587 1:CAS:528:DyaE28XhslCrtL8%3D 59905
35. RH Wilkins 1991 Hemifacial spasm: a review Surg Neurol 36 251 277 10.1016/0090-3019(91)90087-P 1:STN:280:DyaK38%2FlsFamtw%3D%3D 1948626
36. Wilkins RH (1993) Hemifacial spasm and other facial nerve dysfunction syndromes. In: Barrow DL (ed) Surgery of the cranial nerves of the posterior fossa. American Association of Neurological Surgeons, pp 221-233